Tag: OBX-115 Clinical Development

RTW Biotech Opportunities joins $160.5m Series C of Obsidian Therapeutics

businessnewstoday- April 7, 2024 0

RTW Biotech Opportunities Ltd, an investment company listed on the London Stock Exchange and specialized in the life sciences sector, is proud to announce its ... Read More